(dramatic music)
-: IVI was founded in 1997,
the first international organization
headquartered in the Republic of Korea
and the only international organization
anywhere in the world that has a mission to discover,
develop, and deliver safe, effective,
and affordable vaccines for global health.
We have a very unique mission in that we work on vaccines
that the average big vaccine company
wouldn't ever touch because these are vaccines
for the poorest people in the world.
We call them unincentivized vaccines.
There's vaccines for diseases that occur
in areas that are poverty-stricken,
in low and middle income countries around the world
that don't have vaccine solutions
to the problems that exist.
-: We had a mission, we're going to do vaccines.
But we didn't have a clear strategy on how to get there.
We weren't delivering as expected. We were losing money.
We were having a hard time keeping people.
We weren't developing vaccines at the pace we wanted to.
Where BCG fit in is they helped
to put together that strategy.
They helped us to link the vision, the mission,
the strategy, and even into the operations.
And I'd say one of the things that distinguished BCG
from some of the other consulting groups
that I've worked with is they got into the weeds.
They didn't stay at 30,000 feet.
They went right down into the weeds
with us, which we needed.
-: For me personally, I think the opportunity to work
with IBI kind of throughout its transformation journey
has been a real privilege where I really saw
this collective engine of BCG expertise harnessed
to bring the best possible value to our clients.
We were calling global health experts and vaccine experts
in Germany and Paris and DC and Johannesburg,
experts in governance in Singapore and Boston,
and just a host of other BCGers across our private
and public and social sectors.
-: What COVID did is it supercharged everything,
where we were plugging along, knocking out the vaccines.
All of a sudden, it just doubled up in ramp.
(dramatic music)
We were in the right place. We had the right skills.
We had the right team all around the world
that could do this thing.
We had good results at that point.
We were a credible partner to work with.
-: By the time in 2021, when we were ready
to do this next big iteration of the strategy cycle,
IBI was just in this completely different place
and really ready to think boldly about the future.
They had doubled in size financially.
They had been able to diversify their portfolio.
And they'd really bolstered some critical relationships
with donors and with other key stakeholders.
(dramatic music)
-: So we're in a very exciting phase of IVI's growth.
We are opening our first overseas office.
We call it Original Office.
It will be located in Stockholm, in Sweden.
-: As we were preparing these pitches
and talking to different country officials,
it was incredibly energizing to see just the level
of interest and excitement about IVI.
And I think it was a true testament to the immense amount
of work that has happened since 2015 and the fact
that they firmly established themselves
as this nimble player in the global health space.
-: There's some unique models that we want to try
to put together and what we're doing with BCG now,
is can we create partnerships in countries
or in regions such as Africa, where it can pull together
multiple other foundations, multiple other governments,
not just Sweden, not just Korea, but many in Africa
to solve some really big problems?
And that's going to be this whole thing
on a exponential scale.
(dramatic music)